Gene Query: ASNSD1

Dataset Description Geneva Score
Transcriptome analysis of U87 cells upon LINC00152 knockdown 27.42
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 21.58
Human cell line and subcutaneous tumor 18.1
SNHG5 siRNA knock down in HCT116 cells 16.98
RNAseq Analysis in glioblastoma cells treated with Mepazine 16.09
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 15.39
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 15.39
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 14.96
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 14.65
RNA-seq of YB5 cells treated with Proscillaridin A 13.13
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 12.89
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 12.84
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 12.84
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 12.82
Transcriptome of diurnal human blood neutrophils 12.6
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 12.38
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 12.38
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 11.78
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 11.75
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 11.39
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 11.16
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 11.06
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 11.01
Seletive inhibition of CDK9 in DLBCL cell lines 10.91
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 10.79
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 10.61
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 10.61
3’ Uridylation Expands miRNA Target Repertoire 10.51
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 10.46
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 10.17
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 10.16
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 10.09
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 10.0
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 9.95
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 9.92
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 9.89
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 9.67
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 9.63
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 9.61
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 9.59
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 9.54
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 9.32
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 9.3
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 9.24
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 9.23
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 9.0
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 9.0
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 8.88
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 8.78
RNAseq of HEK293 cells after Chtop knockdown 8.77
Co-transcriptional loading of RNA export factors shapes the human transcriptome 8.77
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 8.76
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 8.61
Transcriptomic analyssis following EHMT1/2 inhibition 8.59
miR941 overexpression experiment 8.58
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 8.39
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 8.29
A transcriptome-wide divergence in protein translation scales with LIN28B expression 8.29
LNCaP treated with iBET 8.27
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 8.24
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 8.23
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 8.19
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 8.17
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 8.16
FBXW7 modulates stress response by post-translational modification of HSF1 8.16
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 8.07
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 8.07
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 8.07
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 7.98
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 7.98
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 7.96
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 7.83
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 7.78
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 7.75
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 7.69
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 7.59
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 7.56
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 7.53
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 7.45
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 7.37
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 7.32
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 7.3
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 7.21
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 7.19
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 7.09
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 7.08
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 7.08
ETV7 and interferon response 6.99
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 6.99
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 6.98
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 6.97
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 6.93
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 6.93
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 6.85
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 6.83
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 6.83
Rorc disruption in human FG pancreatic cancer cells 6.75
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 6.74
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 6.71
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 6.67
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 6.65
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 6.65
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 6.58
Lysine benzoylation is a novel histone mark [RNA-seq] 6.57
Lysine benzoylation is a novel histone mark 6.57
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 6.55
Regulation of protein translation during mitosis 6.55
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 6.44
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 6.43
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 6.43
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 6.34
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 6.28
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 6.27
Ribosomal footprinting of CN34-Parental and CN34-LM1a 6.26
Global modulation of signaling pathways by SARM RAD140 in AR/ER+ breast cancer xenografts 6.24
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 6.21
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 6.17
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 6.17
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 6.15
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 6.15
The regulartory role of ZCCHC24 in splicing machinery 6.11
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 6.11
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 6.11
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 6.06
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 6.04
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 6.02
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 5.89
JunB control of keratinocyte-mediated inflammation [RNA-seq] 5.89
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 5.89
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 5.81
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 5.76
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 5.75
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 5.74
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 5.72
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 5.69
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 5.66
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 5.62
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 5.6
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 5.55
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 5.53
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 5.52
Cajal bodies are linked to genome conformation 5.46
Cajal bodies are linked to genome conformation [RNA-Seq] 5.46
Global Mapping of Human RNA-RNA Interactions 5.46
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 5.42
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 5.38
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 5.38
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 5.38
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 5.36
Effect of Hotair overexpression in human breast cancer cell lines 5.35
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 5.32
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 5.3
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 5.28
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 5.23
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 5.23
SETBP1-WT and SETBP1-G870S epigenetic landscapes 5.22
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 5.22
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 5.19
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 5.19
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 5.19
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 5.18
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 5.18
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 5.16
Novel Targeting of Transcription and Metabolism in Glioblastoma 5.15
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 5.14
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 5.11
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 5.07
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 5.01
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 5.01
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 5.01
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 5.0
Tracking distinct RNA populations using efficient and reversible covalent chemistry 4.98
Ribosomal footprinting of MDA-Parental and MDA-LM2 4.96
IMP3 regulated gene expression in breast cancer cells 4.95
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 4.94
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 4.92
Total RNA-seq in ALL-SIL upon TLX1 knockdown 4.91
Genome-wide analysis of the Integrator complex (HTS) 4.89
Genome-wide analysis of the Integrator complex 4.89
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 4.88
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 4.86
Effect of FGF13 depletion on the H460 cell line 4.85
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 4.84
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 4.79
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 4.79
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 4.72
LIN28A modulates splicing and gene expression programs in breast cancer cells 4.72
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 4.7
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 4.69
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 4.67
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 4.67
RNA-seq of MDA-MB-231 cells with TET1 knockout 4.67
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 4.66
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 4.64
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 4.56
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 4.53
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 4.53
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 4.51
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 4.5
Polarized B -cell functions 4.45
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 4.45
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 4.45
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 4.45
mRNA expression profile of Lymphocytes 4.43
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 4.37
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 4.37
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 4.35
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 4.35
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 4.32
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 4.32
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 4.32
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 4.31
RNA-seq of resting and activated CD4+ T cells +-JQ1 4.28
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 4.28
RNA-seq in transgenic cells 4.26
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 4.25
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 4.25
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 4.25
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 4.24
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 4.24
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 4.23
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 4.23
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 4.19
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 4.17
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 4.12
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 4.06
CircRNAome diversity in human mature B-cells, T-cells and monocytes 4.04
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 4.03
STX4 Over-Expression in Human islets 4.01
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 3.99
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 3.98
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 3.91
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 3.91
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 3.9
Gene expression changes due to PARP knockdown in human cells 3.89
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 3.87
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 3.79
Co-regulation of splicing by Rbfox1 and hnRNP M 3.79
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 3.79
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 3.79
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 3.79
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 3.79
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 3.79
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 3.75
The cytokine environment influence on human skin-derived T cells 3.72
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 3.71
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 3.7
RNA sequencing of primary human platelets and in vitro cell lines 3.67
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 3.67
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 3.62
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 3.62
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 3.61
Transcriptome of activated human and mouse MAIT cells 3.6
Proteomics identifies a marker signature of MAPKi resistance in melanoma 3.56
Identification of HOXB13 target genes responsive to BET inhibitors 3.53
Effect of ILF3 on translation during homeostasis and the antiviral response 3.53
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 3.51
Identification of a LIF-responsive replication-competent human β cell 3.5
Integrin signaling regulates YAP/TAZ to control skin homeostasis 3.49
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 3.48
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 3.48
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 3.48
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 3.46
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 3.45
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 3.37
Effect of CHKA knockdown on C4-2 cell transcriptome 3.34
Small-molecule targeting of brachyury transcription factor addiction in chordoma 3.29
Silencing p300 in MCF7 cells to study expression and alternative splicing 3.26
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.25
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 3.23
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 3.19
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 3.17
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 3.13
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 3.06
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 3.05
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 3.0
Epigenetic reprogramming of melanoma cells by vitamin C treatment 2.97
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 2.95
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 2.95
Loss of CREBBP results in gene expression repression in lymphoma cells 2.95
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 2.94
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 2.93
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 2.92
Systematic discovery of endogenous human ribonucleoprotein complexes 2.91
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 2.91
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 2.87
The transcriptome and chromatin accessbility landscape of mammalian germline 2.87
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 2.87
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 2.87
Determining mRNA half-lives on a transcriptome-wide scale 2.86
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 2.82
Discovering human diabetes-risk gene function with genetics and physiological assays 2.81
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 2.78
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 2.78
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 2.77
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 2.77
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 2.75
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 2.75
The contribution of Alu exons to the human proteome 2.75
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 2.75
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 2.74
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 2.74
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 2.74
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 2.71
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 2.7
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 2.7
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 2.66
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 2.65
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 2.63
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 2.63
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 2.63
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 2.62
Interaction between mitoNEET and NAF-1 in cancer cells 2.62
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 2.61
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 2.57
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 2.55
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 2.55
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 2.53
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 2.52
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 2.52
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 2.52
Effect of drugs on transcriptomic profiles 2.51
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 2.5
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 2.49
Characterization of parental and rociletinib-resistant derived H1975 cell lines 2.49
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 2.48
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 2.48
RNA sequencing of human mammary epithelial cells 2.44
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 2.38
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 2.38
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 2.37
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 2.36
RNA expression analysis upon JMJD1C depletion 2.35
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 2.35
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 2.33
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 2.32
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 2.32
6mer seed toxicity in tumour suppressive microRNAs 2.31
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 2.26
Anti-inflammatory effect of indoleacrylic acid (IA) 2.25
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 2.21
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 2.2
The Genetic Landscape of Diamond-Blackfan Anemia 2.19
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 2.18
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 2.17
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 2.17
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 2.15
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 2.13
Gene expression profile in breast cancer cells 2.13
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 2.13
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 2.12
RNA-seq analysis of control and Myc-induced U2OS cells 2.11
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 2.11
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 2.1
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 2.06
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 2.03
Real-time observation of light-controlled transcription in living cells 1.96
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 1.94
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 1.94
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 1.93
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 1.9
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 1.9
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 1.89
An integrative analysis of non-coding regulatory DNA variations associated with autism 1.89
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  1.88
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 1.87
O-glcnAc reprograms cellular energetics 1.85
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 1.83
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 1.79
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 1.79
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 1.76
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 1.73
HBEC-shp53-PCHD7 1.7
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 1.69
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 1.68
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 1.64
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 1.62
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 1.62
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 1.62
RNA sequencing of matched nephrectomy samples [RNA-seq] 1.58
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 1.58
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 1.58
LIN28A Over-expression RNAseq 1.56
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 1.55
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 1.55
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 1.54
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 1.54
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 1.53
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 1.5
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.48
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 1.47
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 1.46
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 1.46
SF3B1 Degron knockdown RNA-seq 1.44
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  1.43
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 1.42
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 1.39
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 1.37
Effect of PRDM11 depletion in U2932 cells 1.37
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 1.34
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 1.34
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 1.33
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 1.32
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 1.32
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 1.31
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 1.27
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 1.27
single cell RNA-seq from GM12878 (ENCSR673UIY) 1.26
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.26
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 1.26
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 1.24
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 1.23
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 1.22
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 1.21
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 1.17
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 1.16
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 1.16
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 1.06
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 1.04
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 1.04
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 1.04
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 1.02
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 1.02
EWSR1 influences alternative splicing through direct and indirect mechanisms 0.92
Transcriptome of human ILC2s; primary vs IL-1b-primed 0.91
Ribosomal protein RPL26 is the principal target of UFMylation 0.91
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 0.9
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 0.89
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 0.88
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 0.88
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 0.87
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 0.87
The MEF2B Regulatory Network - RNA-seq data 0.85
The MEF2B Regulatory Network 0.85
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 0.84
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.81
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 0.81
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.8
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 0.75
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.75
Transcriptional landscape changes during human embryonic stem cell derivation 0.74
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 0.73
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.72
Function and hormonal regulation of GATA3 in human first trimester placentation 0.71
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 0.71
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.71
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 0.65
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.64
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 0.6
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 0.57
Measure transcript integrity using RNA-seq data 0.57
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.56
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.55
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.55
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 0.55
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.54
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 0.54
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 0.54
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 0.52
Expression profiling of MCF-7 cells with treatment of TCDD 0.52
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 0.5
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.49
An siRNA screen identifies CHD4 as a target for epigenetic therapy 0.47
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.46
Oncogenic roles of ARID5B in T-ALL 0.46
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 0.44
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.43
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.42
Global transcriptome analysis of WT versus HEB-/- hESCs 0.42
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.41
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.41
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.41
Human Treg IL-12 stimulation 0.41
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 0.39
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.37
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.31
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 0.3
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 0.3
Human Treg IFNg/IL-10 subpopulations 0.29
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 0.25
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 0.25
Modulation of nonsense-mediated decay by rapamycin 0.24
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 0.21
Modeling Human Cancer-induced Cachexia (Human) 0.19
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.19
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.16
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.15
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.13
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 0.13
RNA-seq data 0.13
siRNA-mediated knockdown 0.13
Transcriptional changes in lymphoma cells induced by LSD1 depletion 0.12
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 0.12
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.1
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.08
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.08
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 0.04
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.04
p53 activity results in DNA replication fork processivity 0.04
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.03


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation